The Pulse
Suki Raises $90 Million to Build Healthcare AI Agents
Suki announced $90 million in Series E financing on October 13, 2026, to expand its healthcare AI tools and build agents for health systems and technology partners. The company says patient encounters supported by its platform grew more tha
AI.info Team · Written with AI ·
Patient encounters climbed more than 190%
Suki says the number of patient encounters supported by its AI grew more than 190% year over year in 2026. On October 13, the Redwood City, California, company announced $90 million in Series E financing to expand its healthcare AI capabilities and develop agents for health systems and health technology companies.
The company also says revenue doubled in 2025 and is on track for similar growth in 2026. Revenue from its partner business has increased more than tenfold over the past two years, according to Suki. The announcement does not disclose a valuation.
From clinical notes to referrals and authorizations
Suki began with clinical documentation, using ambient listening to help produce notes from clinician-patient conversations. Its platform has since expanded into clinical reasoning, revenue cycle work and operational workflows. The new financing is intended to support further development of those capabilities and AI agents.
In an interview with Healthcare Dive, founder and CEO Punit Soni described agents that could handle work after a visit, including referrals and prior authorizations for new medications. He also cited filling orders and scheduling follow-ups. The report describes these as planned capabilities, not tools already deployed to complete those tasks.
“Clinical documentation was never the destination. It was the entry point,” said Punit Soni, founder and CEO of Suki.
Punit Soni, founder and CEO of Suki
Suki announced a related product, Ask, the week before the funding round. It brings clinical knowledge from Wolters Kluwer’s UpToDate Expert AI into clinicians’ workflows, according to the company.
450 health organizations and more than 30 partners
Suki says more than 450 healthcare organizations use its clinician-facing application, while more than 30 technology partners embed its AI in their own products. Those partnerships give the company another route to expand beyond its own clinician app. Healthcare Dive reported that Suki plans to deepen existing integrations and add capabilities such as agents to partner platforms.
“We want to go deep with them. We don't want to add 30 more [partners] necessarily; we want to actually go deeper,” Soni told Healthcare Dive. The strategy could put new functions inside software clinicians and health organizations already use, rather than requiring them to adopt a separate Suki product for each task.
Three new investors join the Series E
Healthier Capital, Crosslink Capital and Hercules Capital joined the round as new investors. Existing institutional investors Venrock, Flare Capital Partners, Hedosophia, Philips Ventures and Zoom Ventures also participated. Aman Mahajan, a partner at Healthier Capital, will join Suki’s board as part of the financing.
Suki says it will use the capital to advance its AI technology, integrations and commercial organization. The announcement gives no launch timetable for the planned agents or identifies which task Suki intends to automate first.